Alcala Martin, Gutierrez-Vega Sebastián, Castro Erica, Guzman-Gutiérrez Enrique, Ramos-Álvarez Maria Pilar, Viana Marta
Department of Chemistry and Biochemistry, Facultad de Farmacia, CEU San Pablo University - CEU Universities, Madrid, Spain.
Red Iberoamericana de Alteraciones Vasculares Asociadas a TRastornos del EMbarazo (RIVA-TREM), Chillán, Chile.
Front Physiol. 2018 Nov 6;9:1569. doi: 10.3389/fphys.2018.01569. eCollection 2018.
The prevalence of obesity in women of childbearing age around the globe has dramatically increased in the last decades. Obesity is characterized by a low-state chronic inflammation, metabolism impairment and oxidative stress, among other pathological changes. Getting pregnant in this situation involves that gestation will occur in an unhealthy environment, that can potentially jeopardize both maternal and fetal health. In this review, we analyze the role of maternal obesity-induced oxidative stress as a risk factor to develop adverse outcomes during gestation, including reduced fertility, spontaneous abortion, teratogenesis, preeclampsia, and intrauterine growth restriction. Evidences of macromolecule oxidation increase in reactive oxygen species generation and antioxidant defense alterations are commonly described in maternal and fetal tissues. Thus, antioxidant supplementation become an interesting prophylactic and therapeutic tool, that yields positive results in cellular, and animal models. However, the results from most meta-analysis studying the effect of these therapies in complicated gestations in humans are not really encouraging. It is still to be analyzed whether these therapies could work if applied to cohorts of patients at a high risk, such as those with low concentration of antioxidants or obese pregnant women.
在过去几十年中,全球育龄妇女的肥胖患病率急剧上升。肥胖的特征是低水平慢性炎症、代谢受损和氧化应激等病理变化。在这种情况下怀孕意味着妊娠将在不健康的环境中发生,这可能会危及母婴健康。在本综述中,我们分析了母体肥胖诱导的氧化应激作为妊娠期发生不良结局的危险因素的作用,这些不良结局包括生育力降低、自然流产、致畸、先兆子痫和胎儿生长受限。母体和胎儿组织中通常描述了活性氧生成增加和抗氧化防御改变导致的大分子氧化增加的证据。因此,补充抗氧化剂成为一种有趣的预防和治疗工具,在细胞和动物模型中产生了积极结果。然而,大多数荟萃分析研究这些疗法对人类复杂妊娠的影响,结果并不令人鼓舞。这些疗法应用于高危患者群体(如抗氧化剂浓度低的患者或肥胖孕妇)是否有效仍有待分析。